Shoulder Innovations, Inc.
NYSE:SI · New York Stock Exchange
-$0.13 today
Vol 0.06M · Avg 0.10M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Stock Ticker Earnings Waterfall
NYSE:SI · Revenue to Net Income
Key Ratios
Analysis
$53.9M of revenue converted into -$44.1M of net income for the selected period. Gross margin is 75.1% and net margin is -88.2%, showing how much revenue survives after costs and taxes. EPS is $-2.17, tying the income statement back to per-share earnings.
Income Statement
Annual data · 3 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $47.3M +49.6% | $31.6M +64.1% | $19.3M | $888.0M | $1.0B | $809.6M |
| Cost of Revenue | $11.1M +52.6% | $7.3M +81.9% | $4.0M | -$1.7B | $344.8M | $725.6M |
| Gross Profit | $36.2M +48.7% | $24.3M +59.4% | $15.3M | $11.6B | $10.3B | $8.9B |
| Gross Margin | 76.5% -0.5pp | 77.0% -2.3pp | 79.2% | 26.4% | 45.5% | 9.8% |
| Research & Development | $7.7M +72.2% | $4.5M +48.6% | $3.0M | $1.2B | $378.4M | $983.2M |
| Selling, General & Admin | $54.8M +58.7% | $34.5M +49.3% | $23.1M | $811.0M | $1.4B | $620.6M |
| Operating Expenses | $62.5M +60.3% | $39.0M +49.2% | $26.1M | -$15.9B | $3.6B | $5.3B |
| Depreciation & Amortization | $3.2M +46.1% | $2.2M +33.8% | $1.6M | $419.0M | $1.2B | $374.2M |
| EBITDA | -$37.1M -206.3% | -$12.1M -18.1% | -$10.3M | $10.0B | $12.6B | -$15.2B |
| EBITDA Margin | -78.4% -40.1pp | -38.3% +14.9pp | -53.2% | 14.3% | 10.0% | 5.6% |
| Operating Income | -$26.3M -79.5% | -$14.7M -34.9% | -$10.9M | $9.0B | $10.6B | $12.3B |
| Operating Margin | -55.6% -9.2pp | -46.3% +10.0pp | -56.4% | 11.2% | 18.7% | 16.6% |
| Interest Income | $0 | $0 | $0 | $875.4M | $1.3B | -$1.5B |
| Interest Expense | $70.0K -94.7% | $1.3M +72.9% | $761.0K | $801.2M | $969.2M | $1.1B |
| Other Income / Expenses | -$14.1M -1355.7% | -$966.0K +46.1% | -$1.8M | $368.6M | -$1.6B | -$1.5B |
| Income Before Tax | -$40.4M -158.4% | -$15.6M -23.4% | -$12.7M | $13.9B | -$15.6B | $3.3B |
| Pre-Tax Margin | -85.3% -35.9pp | -49.4% +16.3pp | -65.7% | 15.4% | 13.3% | 20.8% |
| Income Tax Expense | $0 | $0 | $0 | $375.6M | $666.8M | $1.3B |
| Net Income | -$40.4M -158.4% | -$15.6M -23.4% | -$12.7M | $5.1B | $5.0B | $4.9B |
| Net Margin | -85.3% -35.9pp | -49.4% +16.3pp | -65.7% | 47.3% | 7.4% | 12.4% |
| EPS (Basic) | -$2 -154.5% | -$1 -22.2% | -$1 | $591.2M | $1.2B | $400.8M |
| EPS (Diluted) | -$2 -154.5% | -$1 -22.2% | -$1 | $777.4M | $620.6M | $766.2M |
| Weighted Avg Shares | $20.6M +3.5% | $19.9M +0.0% | $19.9M | $724.2M | $892.2M | $757.8M |
| Weighted Avg Shares (Diluted) | $20.6M +3.5% | $19.9M +0.0% | $19.9M | $566.0M | $319.6M | $1.2B |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Assembly Biosciences, Inc.
NASDAQ:ASMB
$386.20M
Enanta Pharmaceuticals, Inc.
NASDAQ:ENTA
$290.09M
Nautilus Biotechnology, Inc.
NASDAQ:NAUT
$282.12M
Eupraxia Pharmaceuticals Inc.
NASDAQ:EPRX
$212.43M
Inogen, Inc.
NASDAQ:INGN
$172.87M
Nano-X Imaging Ltd.
NASDAQ:NNOX
$119.70M
Outset Medical, Inc.
NASDAQ:OM
$85.64M
Aardvark Therapeutics, Inc. Common Stock
NASDAQ:AARD
$83.67M
SANUWAVE Health, Inc.
NASDAQ:SNWV
$80.96M
MDxHealth S.A.
MDXH
$27.88M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does SI generate?
Shoulder Innovations, Inc. (SI) reported $47.32M of revenue in fiscal 2025.
Is SI profitable?
Shoulder Innovations, Inc. (SI) reported -$40,359,000.00 of net income, with a net margin of -85.3%.
Explore More
Continue the stock analysis
Jump to another research area for this company.